Works matching IS 03065251 AND DT 2012 AND VI 73 AND IP 6
1
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 1014, doi. 10.1111/j.1365-2125.2012.04306.x
- Article
2
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 893, doi. 10.1111/j.1365-2125.2012.04232.x
- Article
3
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 943, doi. 10.1111/j.1365-2125.2012.04243.x
- Article
4
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 861, doi. 10.1111/j.1365-2125.2012.04225.x
- Article
5
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 912, doi. 10.1111/j.1365-2125.2012.04236.x
- Article
6
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 968, doi. 10.1111/j.1365-2125.2012.04247.x
- Article
7
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 878, doi. 10.1111/j.1365-2125.2012.04229.x
- Article
8
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 888, doi. 10.1111/j.1365-2125.2012.04231.x
- Article
9
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 939, doi. 10.1111/j.1365-2125.2012.04242.x
- Article
10
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 983, doi. 10.1111/j.1365-2125.2012.04253.x
- Article
11
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 908, doi. 10.1111/j.1365-2125.2012.04235.x
- Article
12
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 959, doi. 10.1111/j.1365-2125.2012.04246.x
- Green, A. Richard;
- Aronson, Jeffrey K.
- Article
13
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 874, doi. 10.1111/j.1365-2125.2012.04228.x
- Article
14
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 927, doi. 10.1111/j.1365-2125.2012.04239.x
- Article
15
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 884, doi. 10.1111/j.1365-2125.2012.04230.x
- Article
16
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 934, doi. 10.1111/j.1365-2125.2012.04241.x
- Kendall, Martin;
- Enright, Duncan
- Article
17
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 855, doi. 10.1111/j.1365-2125.2012.04263.x
- Article
18
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 900, doi. 10.1111/j.1365-2125.2012.04234.x
- Article
19
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 953, doi. 10.1111/j.1365-2125.2012.04245.x
- Coleman, Jamie J.;
- McDowell, Sarah E.
- Article
20
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 870, doi. 10.1111/j.1365-2125.2012.04227.x
- Article
21
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 924, doi. 10.1111/j.1365-2125.2012.04238.x
- Article
22
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 979, doi. 10.1111/j.1365-2125.2012.04249.x
- Article
23
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 846, doi. 10.1111/j.1365-2125.2012.04179.x
- Goldmacher, Gregory V.;
- Conklin, James
- Article
24
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 931, doi. 10.1111/j.1365-2125.2012.04240.x
- Reynolds, D. John M.;
- Barker, Charlotte I. S.
- Article
25
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 843, doi. 10.1111/j.1365-2125.2012.04233.x
- Article
26
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 948, doi. 10.1111/j.1365-2125.2012.04244.x
- Article
27
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 866, doi. 10.1111/j.1365-2125.2012.04226.x
- Article
28
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 917, doi. 10.1111/j.1365-2125.2012.04237.x
- Buclin, Thierry;
- Gotta, Verena;
- Fuchs, Aline;
- Widmer, Nicolas;
- Aronson, Jeffrey
- Article
29
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 6, p. 973, doi. 10.1111/j.1365-2125.2012.04248.x
- Article